Metropolitan Life Insurance CO Atara Biotherapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

48 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$2.8 - $5.46 $1,831 - $3,570
-654 Reduced 11.24%
5,162 $14,000
Q4 2022

Jun 14, 2023
BUY
$2.85 - $5.18 $1,863 - $3,387
654 Added 12.67%
5,816 $19.1 Million
Q4 2022

Mar 30, 2023
BUY
$2.85 - $5.18 $7,398 - $13,447
2,596 Added 80.62%
5,816 $19,000
Q4 2022

Feb 15, 2023
BUY
$2.85 - $5.18 $7,398 - $13,447
2,596 Added 80.62%
5,816 $19,000
Q3 2022

Jun 14, 2023
SELL
$2.85 - $8.73 $5,534 - $16,953
-1,942 Reduced 37.62%
3,220 $12.2 Million
Q3 2022

Mar 30, 2023
SELL
$2.85 - $8.73 $6,971 - $21,353
-2,446 Reduced 43.17%
3,220 $12,000
Q3 2022

Nov 14, 2022
SELL
$2.85 - $8.73 $6,971 - $21,353
-2,446 Reduced 43.17%
3,220 $12,000
Q2 2022

Jun 20, 2023
BUY
$4.69 - $9.84 $2,363 - $4,959
504 Added 9.76%
5,666 $44,000
Q1 2022

Jun 20, 2023
BUY
$8.44 - $16.89 $4,253 - $8,512
504 Added 9.76%
5,666 $52,000
Q1 2022

Mar 30, 2023
SELL
$8.44 - $16.89 $142,889 - $285,947
-16,930 Reduced 74.92%
5,666 $52,000
Q1 2022

May 12, 2022
SELL
$8.44 - $16.89 $142,889 - $285,947
-16,930 Reduced 74.92%
5,666 $53,000
Q4 2021

Jun 21, 2023
BUY
$14.7 - $19.89 $256,279 - $346,762
17,434 Added 337.74%
22,596 $356,000
Q3 2021

Jun 21, 2023
BUY
$11.99 - $17.9 $209,033 - $312,068
17,434 Added 337.74%
22,596 $404,000
Q2 2021

Jun 21, 2023
BUY
$12.89 - $16.58 $224,724 - $289,055
17,434 Added 337.74%
22,596 $351,000
Q2 2021

Mar 30, 2023
BUY
$12.89 - $16.58 $29,105 - $37,437
2,258 Added 11.1%
22,596 $351,000
Q2 2021

Aug 16, 2021
BUY
$12.89 - $16.58 $291,004 - $374,310
22,576 Added 112880.0%
22,596 $351,000
Q1 2021

Jun 26, 2023
BUY
$14.0 - $20.72 $212,464 - $314,446
15,176 Added 293.99%
20,338 $292 Million
Q1 2021

Mar 30, 2023
SELL
$14.0 - $20.72 $14,070 - $20,823
-1,005 Reduced 4.71%
20,338 $292,000
Q1 2021

May 14, 2021
SELL
$14.0 - $20.72 $298,522 - $441,812
-21,323 Reduced 99.91%
20 $292,000
Q4 2020

Jun 22, 2023
BUY
$12.67 - $26.23 $205,013 - $424,427
16,181 Added 313.46%
21,343 $418,000
Q3 2020

Jun 26, 2023
BUY
$11.92 - $15.87 $192,877 - $256,792
16,181 Added 313.46%
21,343 $276,000
Q3 2020

Mar 30, 2023
BUY
$11.92 - $15.87 $31,897 - $42,468
2,676 Added 14.34%
21,343 $276,000
Q3 2020

Nov 13, 2020
BUY
$11.92 - $15.87 $31,897 - $42,468
2,676 Added 14.34%
21,343 $277,000
Q2 2020

Jun 26, 2023
BUY
$7.53 - $14.93 $101,692 - $201,629
13,505 Added 261.62%
18,667 $271,000
Q2 2020

Mar 30, 2023
BUY
$7.53 - $14.93 $25,617 - $50,791
3,402 Added 22.29%
18,667 $271,000
Q2 2020

Aug 14, 2020
BUY
$7.53 - $14.93 $25,617 - $50,791
3,402 Added 22.29%
18,667 $272,000
Q1 2020

Jul 12, 2023
BUY
$5.69 - $17.78 $57,486 - $179,631
10,103 Added 195.72%
15,265 $129,000
Q1 2020

Mar 30, 2023
BUY
$5.69 - $17.78 $3,248 - $10,152
571 Added 3.89%
15,265 $129,000
Q1 2020

May 15, 2020
BUY
$5.69 - $17.78 $3,248 - $10,152
571 Added 3.89%
15,265 $130,000
Q4 2019

Jul 12, 2023
BUY
$10.89 - $16.79 $103,803 - $160,042
9,532 Added 184.66%
14,694 $242,000
Q4 2019

Mar 30, 2023
SELL
$10.89 - $16.79 $10,389 - $16,017
-954 Reduced 6.1%
14,694 $242,000
Q4 2019

Feb 14, 2020
SELL
$10.89 - $16.79 $10,389 - $16,017
-954 Reduced 6.1%
14,694 $242,000
Q3 2019

Jul 12, 2023
BUY
$12.03 - $19.94 $126,146 - $209,090
10,486 Added 203.14%
15,648 $220,000
Q3 2019

Mar 30, 2023
BUY
$12.03 - $19.94 $27,753 - $46,001
2,307 Added 17.29%
15,648 $220,000
Q3 2019

Nov 14, 2019
BUY
$12.03 - $19.94 $27,753 - $46,001
2,307 Added 17.29%
15,648 $221,000
Q2 2019

Jul 12, 2023
BUY
$19.05 - $41.04 $155,809 - $335,666
8,179 Added 158.45%
13,341 $268,000
Q1 2019

Jul 13, 2023
BUY
$28.4 - $41.74 $232,283 - $341,391
8,179 Added 158.45%
13,341 $530,000
Q1 2019

Mar 30, 2023
BUY
$28.4 - $41.74 $213,710 - $314,093
7,525 Added 129.38%
13,341 $530,000
Q1 2019

May 16, 2019
SELL
$28.4 - $41.74 $80,826 - $118,792
-2,846 Reduced 17.58%
13,341 $530,000
Q1 2019

May 15, 2019
BUY
$28.4 - $41.74 $69,125 - $101,595
2,434 Added 17.7%
16,187 $527,000
Q4 2018

Jul 13, 2023
BUY
$30.9 - $42.97 $265,461 - $369,155
8,591 Added 166.43%
13,753 $477,000
Q4 2018

Feb 14, 2019
BUY
$30.9 - $42.97 $334,956 - $465,794
10,840 Added 372.12%
13,753 $478,000
Q3 2018

Jul 13, 2023
BUY
$35.05 - $43.5 $285,342 - $354,133
8,141 Added 157.71%
13,303 $550 Million
Q3 2018

Nov 14, 2018
SELL
$35.05 - $43.5 $364,169 - $451,965
-10,390 Reduced 78.1%
2,913 $120,000
Q2 2018

Aug 15, 2018
BUY
$35.15 - $51.45 $95,432 - $139,686
2,715 Added 25.64%
13,303 $0
Q1 2018

May 15, 2018
BUY
$18.0 - $48.35 $23,490 - $63,096
1,305 Added 14.06%
10,588 $0
Q4 2017

Feb 15, 2018
SELL
$13.2 - $18.1 $111,315 - $152,637
-8,433 Reduced 47.6%
9,283 $168,000
Q2 2017

Aug 14, 2017
BUY
N/A
17,716
17,716 $248,000

Others Institutions Holding ATRA

# of Institutions
7
Shares Held
2.89M
Call Options Held
0
Put Options Held
0
View Full List

About Atara Biotherapeutics, Inc.

ATRA Quotes by TradingView
  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $1.08B
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email